Pinnacle Bancorp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.95K | Hold |
27
| – | – | ﹤0.01% | 806 |
|
|
2025
Q4 | $4.75K | Sell |
27
-5
| -16% | -$817 | ﹤0.01% | 788 |
|
|
2025
Q3 | $4.48K | Hold |
32
| – | – | ﹤0.01% | 822 |
|
|
2025
Q2 | $4.02K | Buy |
32
+9
| +39% | +$1.12K | ﹤0.01% | 818 |
|
|
2025
Q1 | $3.15K | Buy |
+23
| New | +$3.29K | ﹤0.01% | 825 |
|
|
2024
Q4 | – | Sell |
-45
| Closed | -$8.72K | – | 888 |
|
|
2024
Q3 | $8.72K | Hold |
45
| – | – | ﹤0.01% | 708 |
|
|
2024
Q2 | $10.4K | Hold |
45
| – | – | ﹤0.01% | 662 |
|
|
2024
Q1 | $9.7K | Hold |
45
| – | – | ﹤0.01% | 662 |
|
|
2023
Q4 | $11.6K | Hold |
45
| – | – | ﹤0.01% | 614 |
|
|
2023
Q3 | $11.6K | Hold |
45
| – | – | ﹤0.01% | 587 |
|
|
2023
Q2 | $12.8K | Hold |
45
| – | – | ﹤0.01% | 564 |
|
|
2023
Q1 | $12.5K | Hold |
45
| – | – | ﹤0.01% | 573 |
|
|
2022
Q4 | $12K | Hold |
45
| – | – | ﹤0.01% | 543 |
|
|
2022
Q3 | $12K | Hold |
45
| – | – | 0.01% | 517 |
|
|
2022
Q2 | $9K | Sell |
45
-269
| -86% | -$55K | ﹤0.01% | 574 |
|
|
2022
Q1 | $66K | Sell |
314
-93
| -23% | -$20.2K | 0.02% | 310 |
|
|
2021
Q4 | $98K | Sell |
407
-70
| -15% | -$18K | 0.03% | 254 |
|
|
2021
Q3 | $135K | Sell |
477
-5
| -1% | -$1.64K | 0.05% | 202 |
|
|
2021
Q2 | $167K | Sell |
482
-506
| -51% | -$153K | 0.08% | 178 |
|
|
2021
Q1 | $276K | Sell |
988
-31
| -3% | -$8.36K | 0.13% | 131 |
|
|
2020
Q4 | $250K | Buy |
1,019
+70
| +7% | +$18.1K | 0.15% | 123 |
|
|
2020
Q3 | $269K | Hold |
949
| – | – | 0.19% | 109 |
|
|
2020
Q2 | $254K | Buy |
949
+10
| +1% | +$3.01K | 0.19% | 111 |
|
|
2020
Q1 | $297K | Hold |
939
| – | – | 0.25% | 87 |
|
|
2019
Q4 | $279K | Sell |
939
-106
| -10% | -$29.4K | 0.19% | 103 |
|
|
2019
Q3 | $243K | Sell |
1,045
-224
| -18% | -$52.2K | 0.14% | 112 |
|
|
2019
Q2 | $297K | Buy |
1,269
+25
| +2% | +$5.77K | 0.17% | 92 |
|
|
2019
Q1 | $294K | Sell |
1,244
-59
| -5% | -$18.6K | 0.17% | 91 |
|
|
2018
Q4 | $392K | Buy |
+1,303
| New | +$416K | 0.24% | 66 |
|
|
2017
Q1 | $223K | Buy |
+815
| New | +$230K | 0.16% | 94 |
|
Other funds holding BIIB
VCM
VPM
Pinnacle Bancorp's BIIB Position: Q1 2026 in Review
Pinnacle Bancorp held its Biogen (BIIB) position steady in Q1 2026 at 27 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #806.
Pinnacle Bancorp first reported a position in BIIB in Q1 2017 and has held it in 30 quarters since. The position peaked at $392K in Q4 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Pinnacle Bancorp held 27 shares of Biogen worth $4.95K as of Q1 2026.
- Pinnacle Bancorp left its Biogen share count unchanged in Q1 2026.
- Biogen made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q1 2026, its #806 holding.
- Pinnacle Bancorp first reported a position in Biogen in Q1 2017 and has held it in 30 quarters since.
- Pinnacle Bancorp's Biogen position peaked at $392K in Q4 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.